The purpose of this study is to assess the safety, tolerability, biomarker and cognitive efficacy of investigational products in subjects who are known to have, or are at risk of having an Alzheimer's disease-causing mutation by determining if treatment with the study drug slows the rate of progr

This study will test the safety and tolerability of a medium chain triglyceride (MCT) supplement in those with Alzheimer Disease (AD). 

recruitment poster

Recent evidence suggests a connection between the gut and the brain, and that certain conditions in the gut might be associated with neurological diseases.  Research suggests that people with Alzheimer's Disease differ from healthy controls with respect to the bacteria (microbiome) present in the

The purpose of this study is to validate the English version of a new cognitive screening tool, the "Dépistage Cognitif de Québec" (DCQ).  The DCQ is a valid instrument that can be administered in less than 45 minutes and unlike other screening tools for dementia, it can provide more detailed inf

The purpose of the study is to evaluate the long-term safety and tolerability of aducanumab  in participants who had previously participated in aducanumab studies.